Shiv Dutt Purohit - Böcker

This book covers the recent developments in biopolymer nanocomposite materials and their possible impact on the food packaging industry. The food industry has been one of the highest consumers of plastics for the past two decades, where plastics have been used in huge amounts as food packaging materials.

This book covers the recent developments in biopolymer nanocomposite materials and their possible impact on the food packaging industry. The food industry has been one of the highest consumers of plastics for the past two decades, where plastics have been used in huge amounts as food packaging materials. The generation of non-biodegradable plastic-based municipal solid waste, especially due to food packaging industry, has now become one of the two paramount problems faced by the world today. The other problem is being the wastage of food in humongous quantities annually. With the onset of globalization, food produced in one part of the world became available to people living in another part. However, during transportation and storage, a plethora of food gets wasted due to microbial contamination of chemical oxidation. This book looks into biopolymer nanocomposites, and it’s the ability to address both these issues. It presents the very essence of biopolymer nanocomposite technology with the combination of various nanomaterials and biopolymer to yield a functional product for food packaging, which is demonstrated in the various chapters. In general, this book caters to the needs of students involved in nanotechnology, biotechnology, food technology, industrial chemistry, and many others other interdisciplinary subjects.

This book covers a number of engineered nanotheranostics platforms and nanomedicines applications of FDA-approved medicines for early-stage diagnosis and treatment of cancer. The book focuses on (i) the basic design and bioengineering of safe medicines, (ii) physicochemical understanding of surface engineered medicines and their characteristics, (iii) various examples for site-specific bioimaging and multimode therapies, (iv) stimuli-responsive approaches for targeted drug delivery applications, (v) targeted therapeutics approaches for cancer cells or solid tumor ablations, (vi) targeted mechanisms of administrative biomedicines, (vii) impact of surface modification or engineering of biomedicines for site-selective tumor binding ability, and (vii) requirements for clinical trials and FDA approval. The content of this book appeal to readers who are interested in recent developments of FDA-approved cost-effective rapid cancer imaging and therapeutic platforms.